Call for Targets
In an effort to fast-track the discovery and development of unmet medical technologies, corporations and innovation focused institutions are increasingly forming call for target programs. These programs solicit specific research projects from medical universities based on gaps in an organizations portfolio pipeline. The collaboration formed between each corporation and university varies depending on the structure defined by the call for targets program, but the framework to expedite inventions from discovery to the clinical phase is a shared structure that lays the foundation for these programs to succeed.
OTBD closely monitors call for targets programs and proposals, including:
|Call for Targets and Assays||Call for Proposals|
|Eli Lilly Open Innovation Drug Discovery||Pfizer CTI|
|MRC Technology Collaborative Early Stage Drug Discovery|